Enabling equitable open access to commercially funded research publications | PLOS Medicine
peter.suber's bookmarks 2026-08-30
Summary:
Abstract: Pharmaceutical companies fund much biomedical research, yet many journals restrict open access publishing options for peer-reviewed articles reporting commercially funded research. Expanded publishing options, such as funder-neutral publishing policies, will help address this inequity.